In contrast however, Guillou et al. report that 7 out of 52 (13.5%) of their FUS-CREB3L2 fusion gene positive cases occurred in non-LGFMS neoplasms, of which 4 were diagnosed as sclerosing epithelioid fibrosarcoma [13]. This evidence concerns the gene FUS and neoplasm.